Cargando…
Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis
We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588108/ https://www.ncbi.nlm.nih.gov/pubmed/33134420 http://dx.doi.org/10.1093/ofid/ofaa454 |
_version_ | 1783600313688653824 |
---|---|
author | Selvaraj, Shailendra V Bares, Sara H Havens, Joshua P |
author_facet | Selvaraj, Shailendra V Bares, Sara H Havens, Joshua P |
author_sort | Selvaraj, Shailendra V |
collection | PubMed |
description | We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis. |
format | Online Article Text |
id | pubmed-7588108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75881082020-10-30 Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Selvaraj, Shailendra V Bares, Sara H Havens, Joshua P Open Forum Infect Dis Brief Reports We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis. Oxford University Press 2020-09-24 /pmc/articles/PMC7588108/ /pubmed/33134420 http://dx.doi.org/10.1093/ofid/ofaa454 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Brief Reports Selvaraj, Shailendra V Bares, Sara H Havens, Joshua P Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title | Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title_full | Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title_fullStr | Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title_full_unstemmed | Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title_short | Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis |
title_sort | acute weight gain after switch to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588108/ https://www.ncbi.nlm.nih.gov/pubmed/33134420 http://dx.doi.org/10.1093/ofid/ofaa454 |
work_keys_str_mv | AT selvarajshailendrav acuteweightgainafterswitchtoemtricitabinetenofoviralafenamideforhumanimmunodeficiencyviruspreexposureprophylaxis AT baressarah acuteweightgainafterswitchtoemtricitabinetenofoviralafenamideforhumanimmunodeficiencyviruspreexposureprophylaxis AT havensjoshuap acuteweightgainafterswitchtoemtricitabinetenofoviralafenamideforhumanimmunodeficiencyviruspreexposureprophylaxis |